| Pharmaceutical active ingredients: |
| Naphazoline HydrochloridePheniramine Maleate |
| Available forms, composition and doses of Naphcon-A: |
| Solution; Ophthalmic; Naphazoline Hydrochloride 0.025%; Pheniramine Maleate 0.3% |
| Naphcon-A medical category: |
| Human:Ophthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01GA51 - Naphazoline, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AlconDKSHFirma Chun CheongMetro Drug DistributionSummit |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nafazair A | Naphazoline Hydrochloride; Pheniramine Maleate | Bausch and Lomb |
| Nafcon A | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Naphazole-A | Naphazoline Hydrochloride; Pheniramine Maleate | The Harvard Drug Group |
| Naphazoline Plus | Naphazoline Hydrochloride; Pheniramine Maleate | Parmed Pharmaceuticals |
| Naphazoline; Pheniramine | Naphazoline Hydrochloride; Pheniramine Maleate | Altaire Pharmaceuticals |
| Naphoptic-A | Naphazoline Hydrochloride; Pheniramine Maleate | Optopics Laboratories |
| Ocuhist | Naphazoline Hydrochloride; Pheniramine Maleate | Pfizer |
| Opcon-A | Naphazoline Hydrochloride; Pheniramine Maleate | Bausch and Lomb; Firma Chun Cheong; U.S. Summit |
| Optaphen | Naphazoline Hydrochloride; Pheniramine Maleate | Pascual Laboratories; Optaderm Pharma |
| Refenax Colirio | Naphazoline Hydrochloride; Pheniramine Maleate | Monserrat y Eclair |